SARS-CoV-2 3CLpro-IN-18
Product Specifications
UNSPSC Description
SARS-CoV-2 3CLpro-IN-18 (Compound 3C) is a covalent SARS-CoV-2 3CLpro inhibitor (IC50s: 0.478 μM). SARS-CoV-2 3CLpro-IN-18 inhibits SARS-CoV-2 in Vero E6 cells (EC50= 2.499 μM) with low cytotoxicity (CC50 > 200 μM)[1].
Target Antigen
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-3clpro-in-18.html
Solubility
10 mM in DMSO
Smiles
O=C(N1C2=CC(Cl)=CC=C2CCC3=CC=CC=C31)CSC#N
Molecular Weight
328.82
References & Citations
[1]Ren P, et al. Discovery and Mechanism Study of SARS-CoV-2 3C-like Protease Inhibitors with a New Reactive Group. J Med Chem. 2023 Aug 18.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-155981/SARS-CoV-2-3CLpro-IN-18-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-155981/
Clinical Information
No Development Reported
CAS Number
3032604-29-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items